国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (7): 517-520.

• 综述 • 上一篇    下一篇

过氧化物酶体增殖物激活受体γ在肺癌中的作用研究

付凤莲, 蒋永新   

  1. 650118 昆明医科大学第三附属医院肿瘤研究所
  • 出版日期:2013-07-08 发布日期:2013-07-08
  • 通讯作者: 蒋永新,E-mail:598104374@qq.com E-mail:598104374@qq.com

Roles of peroxisome proliferator activated receptor-γ in lung cancer

FU  Feng-Lian, JIANG  Yong-Xin-   

  1. Cancer Research Institute, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
  • Online:2013-07-08 Published:2013-07-08
  • Contact: JIANG Yong-xin. E-mail:598104374@qq.com

摘要: 过氧化物酶体增殖物激活受体(PPAR)γ是一类配体激活的核转录因子,属于核受体超家族成员,在调节糖和脂肪代谢,肿瘤细胞增殖、分化、凋亡、侵袭和远处转移等方面发挥重要作用。研究显示在人类肺癌组织和多种肺癌细胞株中均有PPARγ表达,且经其配体活化后能显著地干预包括肺癌在内的多种癌的进展和演变。但近来也有资料表明激活PPARγ导致促癌效应。

关键词: 肺肿瘤, 过氧化物酶体增殖物激活受体, 配体, 肿瘤形成过程

Abstract: Peroxisome proliferator activated receptor-γ (PPARγ) is a member of the nuclear receptor superfamily of ligand-activated transcription factors that plays a critical role in regulating glucose and lipid homeostasis, and in the processes of tumor cell proliferation, differentiation, apoptosis, invasion and distant metastasis. Studies demonstrate that PPARγ expression is detected in human lung cancer tissues and numerous lung cancer cell lines. Activation of PPARγ through its ligands impedes significantly a variety of tumor progression, including lung cancer. However, systemic activation of PPARγ has been reported to be protumorigenic in some in vitro systems and in vivo models.

Key words:  Lung neoplasms, Peroxisome proliferator-activated receptors, Ligands, Neoplastic processes